Crescent Capital BDC, Inc.

Crescent Capital BDC, Inc. is a U.S.-listed business development company that provides debt and equity capital to middle-market companies. It is externally managed by an affiliate of Crescent Capital Group, which supplies the investment team, sourcing platform, and credit underwriting capabilities used to originate and monitor investments.

— Crescent Capital BDC, Inc.
%
Senior secured lending55% First-lien and other secured loans to middle-market companies, typically the core of the portfolio.
Unitranche and structured credit20% Single-tranche and other structured debt solutions used in sponsor-backed financings and refinancings.
Subordinated and unsecured debt15% Second-lien and unsecured loans that provide higher-yield exposure with greater credit risk.
Equity and warrants5% Minority equity securities and similar upside instruments attached to debt investments.
Portfolio management and fee income5% Income tied to loan origination, structuring, monitoring, and related investment activity.

Crescent Capital BDC lends primarily to U.S. middle-market companies that need private capital for growth,...

  • U.S. middle-market companiesprimary

    Primary borrowers that use private credit for growth, refinancing, and general corporate purposes.

  • Private equity-sponsored companiesprimary

    Sponsor-backed businesses that need leveraged financing for acquisitions, buyouts, or recapitalizations.

  • Companies with predictable cash flowssecondary

    Borrowers selected for recurring earnings and repayment visibility, which supports underwriting.

  • Companies in industries with barriers to entrysecondary

    Businesses that can support debt service through competitive advantages and resilient market positions.

The company is organized in the United States and listed on Nasdaq, and its lending activity is focused on U.S...

  • •United States is the core lending market
  • •Nasdaq listing and Maryland incorporation anchor the business in the U.S.
  • •Crescent support platform spans six offices in the U.S. and Europe
  • •Portfolio exposure is driven by U.S. middle-market credit conditions
  • •No country-level revenue disclosure was provided in the excerpts

The strategy is to originate and hold a diversified portfolio of private credit investments in middle-market companies,...

01
Originate attractive middle-market credit opportunitiesshort-term

The company’s return profile depends on access to proprietary deal flow and disciplined underwriting.

02
Preserve credit quality through senior secured structuresmedium-term

First-lien and unitranche loans are intended to reduce loss severity in stressed scenarios.

03
Maintain portfolio diversification and active monitoringmedium-term

Diversification and ongoing surveillance help manage idiosyncratic default risk in private credit.

The main risk is credit loss on loans to private middle-market borrowers, which typically have less financial...

high

Credit losses on middle-market loans

Borrowers may have limited financial resources and be more vulnerable to downturns.

Scope
Senior secured, unitranche, second lien, and unsecured loan portfolio
Materiality
high
high

Dependence on Crescent investment professionals

The BDC has no employees and relies on the Adviser and Crescent resources.

Scope
Origination, underwriting, monitoring, and portfolio management
Materiality
high
high

Macro and rate-cycle sensitivity

Recession, inflation, and tighter credit conditions can weaken borrower performance.

Scope
Portfolio credit quality and fair value marks
Materiality
high
medium

Limited transparency of private companies

The company relies on diligence and may not have full public-market disclosure.

Scope
All private portfolio investments
Materiality
high
medium

Conflicts in allocation of investment opportunities

Crescent manages multiple funds and may allocate attractive deals elsewhere.

Scope
Deal sourcing and co-investment opportunities
Materiality
medium
Fair value of portfolio investments
Can materially change net asset value and reported earnings
Non-accrual investments
Affects revenue, yield, and credit quality metrics
Revenue recognition
Can create timing differences in quarterly income
Income taxes and RIC status
Shapes dividend policy and tax expense presentation

CRESCENT BIOPHARMA, INC.

CBIO · Pharmaceutical Preparations

Palmer Square Capital BDC Inc.

PSBD

Chicago Atlantic BDC, Inc.

LIEN

TriplePoint Venture Growth BDC Corp.

TPVG

BCP Investment Corp

BCIC

Investcorp Credit Management BDC, Inc.

ICMB

: 28.4.2026